- Investing Ideas
- Indian Pharmaceuticals & Biotech Healthy potentially undervalued
Indian Pharmaceuticals & Biotech Healthy potentially undervalued
Results
3
1 new
Companies which are potentially undervalued and in an acceptable financial position.
3 companies
Eris Lifesciences
Market Cap: ₹190.3b
Provides domestic branded formulations for chronic and sub-chronic therapies in India and internationally.
New
ERIS
₹1,373.00
7D
-1.3%
1Y
-24.1%
Alembic Pharmaceuticals
Market Cap: ₹159.1b
An integrated pharmaceutical company, develops, manufactures, markets, and sells pharmaceutical products in India and internationally.
APLLTD
₹809.40
7D
-1.2%
1Y
-14.5%
Dr. Reddy's Laboratories
Market Cap: ₹966.8b
Operates as an integrated pharmaceutical company North America, Europe, India, Russia, and internationally.
500124
₹1,160.65
7D
2.2%
1Y
-4.4%